A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors.
Menon M, Elliott R, Bowers L, Balan N, Rafiq R, Costa-Cabral S, Munkonge F, Trinidade I, Porter R, Campbell AD, Johnson ER, Esdar C, Buchstaller HP, Leuthner B, Rohdich F, Schneider R, Sansom O, Wienke D, Ashworth A, Lord CJ.
Menon M, et al. Among authors: ashworth a.
Sci Rep. 2019 Jan 17;9(1):201. doi: 10.1038/s41598-018-36447-4.
Sci Rep. 2019.
PMID: 30655555
Free PMC article.